Securities Class Actions – Page 5 – ClaimsFiler

Case Type: Securities Class Actions

Astrazeneca PLC (NYSE: AZN)

On December 23, 2024, AstraZeneca PLC was sued for violations of the federal securities laws in the  United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired publicly traded AstraZeneca securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

On December 19, 2024, Joint Stock Company Kaspi.kz was sued for violations of the federal securities laws in the  United States District Court for the Central District of California on behalf of investors who purchasedor otherwise acquired publicly traded Kaspi.kz securities between January 19, 2024 and September 19, 2024 inclusive (the “Class Period”).

On December 17, 2024, Applied Therapeutics, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”).

On December 16, 2024, MGP Ingredients, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of all purchasers of shares of the common stock of MGPI between May 4, 2023 through October 30, 2024, inclusive (the “Class Period”).

On December 13, 2024, Enphase Energy, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Enphase common stock between April 25, 2023, and October 22, 2024, inclusive (the “Class Period”).

On December 12, 2024, Sun Communities, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Michigan on behalf of investors who purchased or otherwise acquired SUI securities between February 28, 2019 and September 24, 2024, inclusive (the “Class Period”).

On December 12, 2024, Cassava Sciences, Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Texas on behalf of investors who purchased or  otherwise acquired Cassava securities between February 7, 2024 to November 24, 2024, inclusive (the “Class Period”).

On December 9, 2024, Kyverna Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s shares pursuant and/or traceable to the Company’s registration statement issued in connection with its February 2024 initial public offering (“IPO”).

On December 9, 2024, Marqeta, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired publicly traded Marqeta securities between August 7, 2024 and November 4, 2024, both dates inclusive (the “Class Period”).

On December 6, 2024, DMC Global Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased DMC Global securities between May 3, 2024 and November 4, 2024, inclusive (the “Class Period”).

On December 4, 2024, Five9, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or acquired Five9 securities, including call options, between June 4, 2024 through the close of trading on August 8, 2024, inclusive (the “Class Period”).

On December 4, 2024, ASP Isotopes Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired ASP Isotopes securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).

On December 3, 2024, Aehr Test Systems, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Aehr securities between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”).

On December 3, 2024, Symbotic Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired publicly traded Symbotic securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”).

On December 2, 2024, Customers Bancorp, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased or otherwise
acquired publicly traded Customers Bancorp securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).

On November 26, 2024, Dentsply Sirona Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased Dentsply common stock between December 1, 2022 and November 6 2024, inclusive (the “Class Period”).

On November 25, 2024, Warner Bros. Discovery, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired WBD securities between February 23, 2024 and August 7, 2024, both dates inclusive (the “Class Period”).

On November 24, 2024, Match Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired publicly traded Match Group securities between May 2, 2023 and November 6, 2024, inclusive (the “Class Period”).

On November 22, 2024, Celsius Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Florida on behalf of all purchasers of Celsius common stock
during the period between February 29, 2024 and September 4, 2024 (the “Class Period”).

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK